Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium- Mycobacterium intracellulare bacteremia in patients with AIDS

F. De Lalla, R. Maserati, P. Scarpellini, P. Marone, R. Nicolin, F. Caccamo, R. Rigoli

Research output: Contribution to journalArticlepeer-review

Abstract

A combination of clarithromycin, ciprofloxacin, and amikacin for the treatment of Mycobacterium avium-Mycobacterium intracellulare bacteremia was evaluated in 12 AIDS patients. Mycobacteremia cleared in all patients by 2 to 8 weeks of treatment, and symptoms resolved. Four patients died; all had negative blood cultures until death, and disseminated M. avium-M. intracellulare complex infection was not considered the primary cause of death.

Original languageEnglish
Pages (from-to)1567-1569
Number of pages3
JournalAntimicrobial Agents and Chemotherapy
Volume36
Issue number7
Publication statusPublished - 1992

ASJC Scopus subject areas

  • Pharmacology (medical)

Fingerprint Dive into the research topics of 'Clarithromycin-ciprofloxacin-amikacin for therapy of Mycobacterium avium- Mycobacterium intracellulare bacteremia in patients with AIDS'. Together they form a unique fingerprint.

Cite this